PI
BEAT

PEAK6 Investments’s BioTelemetry, Inc. BEAT Stock Holding History

PEAK6 Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,200
Closed -$2.9M – 5903
2020
Q4 		$2.9M Sell
40,200
-4,600
-10% -$241K 0.01% 1534
2020
Q3 		$2.04M Sell
44,800
-133,600
-75% -$5.58M 0.01% 1644
2020
Q2 		$8.06M Buy
178,400
+69,900
+64% +$3.13M 0.03% 569
2020
Q1 		$4.18M Buy
108,500
+107,400
+9,764% +$4.94M 0.02% 603
2019
Q4 		$51K Sell
1,100
-32,000
-97% -$1.39M ﹤0.01% 3033
2019
Q3 		$1.35M Sell
33,100
-14,500
-30% -$626K 0.01% 1546
2019
Q2 		$2.29M Sell
47,600
-1,100
-2% -$57.8K 0.02% 1182
2019
Q1 		$3.05M Sell
48,700
-900
-2% -$61.8K 0.02% 1013
2018
Q4 		$2.96M Sell
49,600
-54,100
-52% -$3.25M 0.02% 957
2018
Q3 		$6.68M Buy
+103,700
New +$5.79M 0.03% 639

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

PEAK6 Investments's BEAT Position: Q4 2020 in Review

PEAK6 Investments sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 6,910 shares — an estimated $362K sold.

PEAK6 Investments first reported a position in BEAT in Q3 2019 and held it in 4 quarters. The position peaked at $3.3M in Q2 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • PEAK6 Investments reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • PEAK6 Investments sold 6,910 BioTelemetry, Inc. shares in Q4 2020, an estimated $362K.
  • PEAK6 Investments first reported a position in BioTelemetry, Inc. in Q3 2019 and held it in 4 quarters.
  • PEAK6 Investments's BioTelemetry, Inc. position peaked at $3.3M in Q2 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on PEAK6 Investments's 13F filing for Q4 2020, filed 12 Feb 2021.